Tech Company Financing Transactions
MindWalk Funding Round
MindWalk, operating out of Austin, raised $30 million from Sanabil 500.
Transaction Overview
Company Name
Announced On
9/14/2026
Transaction Type
Debt
Amount
$30,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The facility is intended to support MindWalk's biologics programs, commercial expansion, working capital, and general corporate purposes.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
823 Congress Ave 300
Austin, TX 78701
USA
Austin, TX 78701
USA
Phone
Website
Email Address
Not Recorded
Overview
MindWalk is a Bio-Native AI company transforming biologics discovery and drug development. We sit at a rare intersection: artificial intelligence, multi-omics data, and advanced wet lab research -- three disciplines that are too often separated, but far more powerful when built to work together. Our vision is to fundamentally change how drugs are discovered.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jennifer Bath
Chief Financial Officer
R. Scott Areglado
Chief Technical Officer
Ingrid Brands
Chief Technical Officer
Dirk Van Hyfte
Vice President
Shuji Sato
VP - Bus. Development
Frédéric Chabot
VP - Bus. Development
Thomas Lynch
VP - Customer Service
Kari Graber
VP - Marketing
Lori Anderson
Browse more venture capital transactions:
Prev: 9/14/2026: Shennon Biotechnologies venture capital transaction
Next: 9/14/2026: Kaiko venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records reported here come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs